Showing results (21-30 of 228) with videos related to

Sort By:
Pageof 23
Behavioral and Neural Biology|January 1, 1990
Characterization of the cognitive effects of combined muscarinic and nicotinic blockadeE D Levin, J E Rose, S R McGurk, et al.
Pharmacology, Biochemistry, and Behavior|August 1, 1989
Reversal of a mecamylamine-induced cognitive deficit with the D2 agonist, LY 171555E D Levin, S R McGurk, J E Rose, et al.
Behavioral and Neural Biology|November 1, 1990
Cholinergic-dopaminergic interactions in cognitive performanceE D Levin, S R McGurk, J E Rose, et al.
Pharmacology, Biochemistry, and Behavior|January 1, 1993
Sertraline attenuates hyperphagia in rats following nicotine withdrawalE D Levin, S J Briggs, N C Christopher, et al.
Clinical Pharmacology and Therapeutics|March 1, 1990
Transdermal nicotine facilitates smoking cessationJ E Rose, E D Levin, F M Behm, et al.
Drug and Alcohol Dependence|January 1, 1993
Clinical evaluation of a citric acid inhaler for smoking cessationF M Behm, C Schur, E D Levin, et al.
Drug and Alcohol Dependence|October 1, 1993
Clinical trials using ascorbic acid aerosol to aid smoking cessationE D Levin, F Behm, E Carnahan, et al.
Physiology & Behavior|March 10, 2001
The nicotinic antagonist mecamylamine preferentially inhibits cocaine vs. food self-administration in ratsE D Levin, T Mead, A H Rezvani, et al.
Behavioral and Neural Biology|March 1, 1990
Chronic nicotine and withdrawal effects on radial-arm maze performance in ratsE D Levin, C Lee, J E Rose, et al.
Clinical Pharmacology and Therapeutics|July 1, 1994
Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment aloneJ E Rose, F M Behm, E C Westman, et al.
Pageof 23